Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma

NCT04055558 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT04055558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04055558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 25, 2019
Completion date
March 18, 2022
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

childhood leukemia and lymphoma